Maria Immaculata  Iwo

Maria Immaculata Iwo


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in RASAYAN Journal of Chemistry
Verified
Journal Article
Open access
DPD. H. S. Palupi
D. H. S. Palupi
DRD. S. Retnoningrum
D. S. Retnoningrum
MIMaria Immaculata Iwo
Maria Immaculata Iwo
ASA. A. Soemardji
A. A. Soemardji

23 March 2017 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
MIMaria Immaculata Iwo
Maria Immaculata Iwo
SSSergia Louisa Sjahlim
Sergia Louisa Sjahlim
SRSiti Farah Rahmawati
Siti Farah Rahmawati
Vernonia amygdalina has been shown to have antioxidant activity, and is also expected to have hepatoprotective activity. This study was conducted to study the effect of V. amygdalina ethanol extracts on intoxicated rat livers. Fresh leaves were extracted in ethanol, and the hepatoprotective activity was tested on male Wistar rats induced with a combination of isoniazid (INH) and rifampicin. Parameters observed were the activity of the enzyme alanine transferase (ALT), serum albumin levels, liver index, and histopathological of the rat liver. The results showed that 50 and 100 mg/kg rat body weight of V. amygdalina ethanol extracts could prevent liver intoxication, starting on day 14. Based on serum albumin concentrations and ALT activity, the high dose extract (100 mg/kg) was more potent as a hepatoprotective agent compared to the extract at a low dose (50 mg/kg). The group of rats treated with a high dose extract showed normal liver index compared to the positive control. Through histology examination, the liver of rats treated with a high dose extract (100 mg/kg) showed minimal liver cell structure damage, and showed similar patterns to the normal rat. Based on these results, it can be concluded that V. amygdalina ethanol extracts can be used to protect the liver in a combination of INH and rifampicin as antituberculosis treatment.

1 January 2022 in Brazilian Journal of Biology
Verified
Journal Article
Open access
LDL. P. Dwita
L. P. Dwita
MIMaria Immaculata Iwo
Maria Immaculata Iwo
RMR. Mauludin
R. Mauludin
ELElfahmi
Elfahmi
Piper cubeba contains various types of lignans. These compounds have been found to have potential pharmacological activities, one being a neuroprotector through an antioxidant mechanism, especially in the brain. This study examined the antioxidant activity of the lignan-rich fraction of P. cubeba (LF) in rat brains. The rats were given LF (200 and 400 mg/kg), Vitamin C (200 mg/kg), and a carrier as the control group for one-week p.o. The following day, rat brains were collected for antioxidant tests, including examining lipid peroxide inhibition, superoxide dismutase and catalase activity, and determination of nitric oxide (NO) concentration. The phytochemical compounds were analyzed with thin-layer chromatography (TLC), ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS), and gas chromatography-mass spectrometry (GC-MS). Test results show that the LF of both doses of 200 and 400 mg/kg could significantly increase antioxidant activity in the brain by inhibiting lipid peroxidation. LF could also increase catalase, despite the decrease in superoxide dismutase activity. Reduction in NO only occurred in the LF-200 group, while LF-400 showed insignificant results compared to the control group. In conclusion, LF showed potential as an antioxidant in the brain and could be beneficial for treating neurological diseases.

28 March 2022 in Journal Of Vocational Health Studies
Verified
Journal Article
Open access
PDF file
DPDicki Bakhtiar Purkon
Dicki Bakhtiar Purkon
FFFaizah Min Fadhlillah
Faizah Min Fadhlillah
TMTonny Cortis Maigoda
Tonny Cortis Maigoda
MIMaria Immaculata Iwo
Maria Immaculata Iwo
ASAdreanus Andaja Soemardji
Adreanus Andaja Soemardji
YSYayat Sudaryat
Yayat Sudaryat
Background: Liverworts are a group of plants from the Marchantia genus containing various biologically active compounds and comprised of 65 species worldwide. This plant species belongs to the Marchantiaceae family, which was used empirically in China, North America, Ancient Greece, and Indonesia to treat open wounds, burns, hepatotoxicity, and infection prevention. Now, liverworts have great potential as medicinal and nutraceutical products because of their phytochemical content and diversity of pharmacological activities. Purpose: This review focuses on secondary metabolites obtained from the thalloid and whole plant parts (herbs) and the compilation of their pharmacological activities, which are still poorly documented. Review: This review article obtained related information through extensive international journals (online) scientific databases and offline (books) related to all searches of the species of the genus Marchantia which included: phytochemical content (secondary metabolites) and various pharmacological activities which were collected and compared all results of literature studies from various aspects. Some of the secondary metabolites are Marchantin A, B, D dan E; Paleatin B; Perrottetin F, and Plagiochin E, which have various pharmacological activities. Various results regarding all the therapeutic properties of the genus Marchantia have been produced in the world such as: antibacterial, antifungal, antioxidant, cytotoxic activity, anti-inflammatory, cardiotonic, hepatoprotective, muscle relaxant, antiosteoporosis, and skin care. Conclusion: Therefore, the potential for the development of medicinal, supplementary and nutraceutical products from various Marchantia species is very large and broad for the future.

7 November 2023 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
RNRahma Nafiah
Rahma Nafiah
YSYeyet Cahyati Sumirtapura
Yeyet Cahyati Sumirtapura
SDSasanti Tarini Darijanto
Sasanti Tarini Darijanto
MIMaria Immaculata Iwo
Maria Immaculata Iwo
This study aimed to develop a microemulsion formula that can increase the solubility and stability of forskolin and its safety for topical use. The materials used for the development of the microemulsion formula were triglyceride oil, non-ionic surfactants, and polyethylene glycol (PEG) for cosurfactants, which were selected on the basis of the results of the forskolin solubility test using high performance liquid chromatography (HPLC). The microemulsion was formulated by the phase titration method. Formula stability was determined by storage for 90 days in a refrigerator at room temperature, and an accelerated stability test was performed by determining globule size, forskolin concentration, and pH. The safety of using microemulsions was determined by skin irritation tests on albino rabbits. The optimum microemulsion formula consisted of Maisine® CC, polyoxyethylene sorbitan 20 (POE 20), and PEG 400 with a ratio of 4:25:5 w/v, which increased the solubility of forskolin the most, namely 2.19 mg mL-1. Based on globule size (<50 nm), forskolin concentration (2 mg.mL-1), and pH (6.0-6.35), the formula was stable in refrigerator storage and room temperature but unstable in the accelerated stability test (40 °C) starting on day 21. This optimum formula exhibits a primary irritation index (PII) of 0.11, which is categorized as feeble irritation and can be ignored. The microemulsion prepared by the phase titration method containing Maisine® CC, POE 20, and PEG 400 (4:25:5, w/v) as a base and 0.2% forskolin was stable in refrigerator storage and at room temperature. This microemulsion is mild or negligible irritant with a PII: 0.11.

18 December 2022 in Journal Of Tropical Pharmacy And Chemistry
Verified
Journal Article
Open access
PDF file
MIMaria Immaculata Iwo
Maria Immaculata Iwo
AAAmirah Adlia
Amirah Adlia
SSSilviyanita Isna Septila
Silviyanita Isna Septila
YPYennie Agnes Pratama
Yennie Agnes Pratama
DPDicki Bakhtiar Purkon
Dicki Bakhtiar Purkon
Platelet aggregation has the potential to form thrombi and result in cardiovascular system diseases such as myocardial infarction and ischemic stroke - one of the leading causes of death globally. Traditionally, people use binahong leaves as blood thinners. Therefore, this study aims to obtain scientific data on the efficacy of binahong leaf as antithrombotic. The efficacy test was carried out on male Swiss-Webster mice. The results showed that the ethanol extract of binahong leaves at doses of 50 (BLEE50) and 100 mg/kg bw (BLEE100) could increase bleeding time on H7 (7.61±1.79% and 3.72±1.76% vs 1.08±0.90%) and H14 (13.81±4.42% and 5.06±2.30% vs 1.66±1.09%) and coagulation time at H7 (5.01±1.36% and 4.18±1.67% vs 1.38±1.08%) and at H14 (7.92±1.97% and 7.19±1.96% vs 1.70±1.10%) significantly (p<0.05). The two doses of BLEE were formulated in the form of nanoemulsions with the Self Nano Emulsifying Drug Delivery System (NBLEE50 and NBLEE100) were also able to prolong bleeding time and coagulation time significantly (p<0.01) but only NBLEE50 prolonged bleeding time (p<0.05) significantly against BLEE50. In the test of the anti-platelet aggregation effect with ADP as an inducer, both doses of BLEE and the nanoemulsion preparation (NBLEE) could significantly (p70% which was not different from the standard (acetylsalicylic acid). In the antioxidant effect test using the DPPH method, BLEE has an IC50 = 66.08?g/mL which is classified as a strong antioxidant. Both doses of BLEE and its NBLEE could significantly (p<0.01) inhibit lipid peroxidation in plasma and liver and NO radicals formation. BLEE50 can significantly (p<0.05) reduce mean platelet volume (6.05±0.24fL vs 6.55±0.34fL) and platelet distribution width (8.52±0.36% vs 9.25±0.42%). Based on those results, BLEE has the potential to be used as an antiplatelet aggregation and antioxidant.